- Home
- MKSI vs PCVX Comparison
MKSI vs PCVX Comparison
Compare MKSI & PCVX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MKSI
- PCVX
- Stock Information
- Founded
- MKSI 1961
- PCVX 2013
- Country
- MKSI United States
- PCVX United States
- Employees
- MKSI N/A
- PCVX N/A
- Industry
- MKSI Industrial Machinery/Components
- PCVX Biotechnology: Pharmaceutical Preparations
- Sector
- MKSI Industrials
- PCVX Health Care
- Exchange
- MKSI Nasdaq
- PCVX Nasdaq
- Market Cap
- MKSI 9.6B
- PCVX 12.5B
- IPO Year
- MKSI 1999
- PCVX 2020
- Fundamental
- Price
- MKSI $109.88
- PCVX $115.18
- Analyst Decision
- MKSI Buy
- PCVX Strong Buy
- Analyst Count
- MKSI 10
- PCVX 7
- Target Price
- MKSI $143.30
- PCVX $147.50
- AVG Volume (30 Days)
- MKSI 791.2K
- PCVX 1.5M
- Earning Date
- MKSI 10-30-2024
- PCVX 11-04-2024
- Dividend Yield
- MKSI 0.80%
- PCVX N/A
- EPS Growth
- MKSI N/A
- PCVX N/A
- EPS
- MKSI 0.12
- PCVX N/A
- Revenue
- MKSI $3,580,000,000.00
- PCVX N/A
- Revenue This Year
- MKSI N/A
- PCVX N/A
- Revenue Next Year
- MKSI $10.00
- PCVX N/A
- P/E Ratio
- MKSI $959.69
- PCVX N/A
- Revenue Growth
- MKSI N/A
- PCVX N/A
- 52 Week Low
- MKSI $63.44
- PCVX $44.20
- 52 Week High
- MKSI $147.40
- PCVX $121.06
- Technical
- Relative Strength Index (RSI)
- MKSI 46.96
- PCVX 73.46
- Support Level
- MKSI $107.40
- PCVX $113.56
- Resistance Level
- MKSI $115.58
- PCVX $121.06
- Average True Range (ATR)
- MKSI 4.42
- PCVX 5.15
- MACD
- MKSI 0.52
- PCVX 0.30
- Stochastic Oscillator
- MKSI 49.12
- PCVX 56.27
About MKSI MKS Instruments Inc.
MKS Instruments Inc is engaged in providing instruments, subsystems, and process control systems used to measure, monitor, deliver, and control parameters of manufacturing processes. The company's product portfolio includes instruments, components, and systems required in manufacturing products such as flat panel displays, medical devices, and electronic materials, among others used in industrial technologies, semiconductors, life and health sciences, and research and defense markets. The company organizes itself into three reportable business segments: Vacuum Solutions, Photonics Solutions, and Materials Solutions. The Vacuum Solutions segment contributes the majority of the company's revenue, and the majority of its revenue is earned in the United States.
About PCVX Vaxcyte Inc.
Vaxcyte Inc is a vaccine company seeking to improve global health by developing novel vaccines to treat patients suffering from the most common and deadly diseases. Its product comprises. of Pneumococcal conjugate vaccine. The firm's product candidate consists of VAX-24, VAX-A1, and VAX-PG.